{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:12:39Z","timestamp":1778598759025,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,12]]},"DOI":"10.7759\/cureus.108721","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:40:16Z","timestamp":1778596816000},"source":"Crossref","is-referenced-by-count":0,"title":["Bacteriophage Intervention in Pseudomonas aeruginosa-Induced Corneal Ulceration: A Multifaceted Study Assessing Therapeutic Efficacy in Surrogate Bacterial and Animal Models"],"prefix":"10.7759","author":[{"given":"Aalok","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavanya","family":"Anuranjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayank","family":"Gangwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arup","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopal","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0770","article-title":"The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture","volume":"48","author":"Gipson IK","year":"2007","unstructured":"Gipson IK. The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture. Invest Ophthalmol Vis Sci. 2007, 48:4390; 4391-8. 10.1167\/iovs.07-0770","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(81)90145-4","article-title":"Clinical biochemistry of tears","volume":"2","author":"Van Haeringen NJ","year":"1981","unstructured":"Van Haeringen NJ. Clinical biochemistry of tears. Surv Ophthalmol. 1981, 2:84-96. 10.1016\/0039-6257(81)90145-4","journal-title":"Surv Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6939","article-title":"Diversity of bacteria at healthy human conjunctiva","volume":"52","author":"Dong Q","year":"2011","unstructured":"Dong Q, Brulc JM, Iovieno A, et al.. Diversity of bacteria at healthy human conjunctiva. Invest Ophthalmol Vis Sci. 2011, 52:5408-13. 10.1167\/iovs.10-6939","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0b013e3180439c3e","article-title":"Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review","volume":"84","author":"Willcox MD","year":"2007","unstructured":"Willcox MD. Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. Optom Vis Sci. 2007, 84:273-8. 10.1097\/OPX.0b013e3180439c3e","journal-title":"Optom Vis Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1444-0938.2010.00536.x","article-title":"Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins","volume":"94","author":"Willcox MD","year":"2011","unstructured":"Willcox MD. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins. Clin Exp Optom. 2011, 94:161-8. 10.1111\/j.1444-0938.2010.00536.x","journal-title":"Clin Exp Optom"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.resmic.2007.07.005","article-title":"On an invisible microbe antagonistic toward dysenteric bacilli: brief note by Mr. F. D'Herelle, presented by Mr. Roux. 1917","volume":"158","author":"D'Herelle F","year":"2007","unstructured":"D'Herelle F. On an invisible microbe antagonistic toward dysenteric bacilli: brief note by Mr. F. D'Herelle, presented by Mr. Roux. 1917. Res Microbiol. 2007, 158:553-4. 10.1016\/j.resmic.2007.07.005","journal-title":"Res Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.40.4.793-802.1976","article-title":"Who discovered bacteriophage?","volume":"40","author":"Duckworth DH","year":"1976","unstructured":"Duckworth DH. Who discovered bacteriophage?. Bacteriol Rev. 1976, 40:793-802. 10.1128\/MMBR.40.4.793-802.1976","journal-title":"Bacteriol Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1086\/374001","article-title":"Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11","volume":"187","author":"Matsuzaki S","year":"2003","unstructured":"Matsuzaki S, Yasuda M, Nishikawa H, et al.. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J Infect Dis. 2003, 187:613-24. 10.1086\/374001","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ph12010035","article-title":"Phages for phage therapy: isolation, characterization, and host range breadth","volume":"12","author":"Hyman P","year":"2019","unstructured":"Hyman P. Phages for phage therapy: isolation, characterization, and host range breadth. Pharmaceuticals (Basel). 2019, 12:35. 10.3390\/ph12010035","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047742","article-title":"Pseudomonas aeruginosa keratitis in mice: effects of topical bacteriophage KPP12 administration","volume":"7","author":"Fukuda K","year":"2012","unstructured":"Fukuda K, Ishida W, Uchiyama J, et al.. Pseudomonas aeruginosa keratitis in mice: effects of topical bacteriophage KPP12 administration. PLoS One. 2012, 7:e47742. 10.1371\/journal.pone.0047742","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02071-21","article-title":"Considerations for the use of phage therapy in clinical practice","volume":"66","author":"Suh GA","year":"2022","unstructured":"Suh GA, Lodise TP, Tamma PD, et al.. Considerations for the use of phage therapy in clinical practice. Antimicrob Agents Chemother. 2022, 66:e0207121. 10.1128\/AAC.02071-21","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/489024-bacteriophage-intervention-in-pseudomonas-aeruginosa-induced-corneal-ulceration-a-multifaceted-study-assessing-therapeutic-efficacy-in-surrogate-bacterial-and-animal-models","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:40:17Z","timestamp":1778596817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/489024-bacteriophage-intervention-in-pseudomonas-aeruginosa-induced-corneal-ulceration-a-multifaceted-study-assessing-therapeutic-efficacy-in-surrogate-bacterial-and-animal-models"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.108721","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,12]]}}}